Cargando…
High Circulating Plasma Soluble Receptor for Advanced Glycation End-Products in Early COVID-19–associated Acute Respiratory Distress Syndrome: Pathophysiological Significance?
Autor principal: | Jain, Amit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Thoracic Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787241/ https://www.ncbi.nlm.nih.gov/pubmed/34727514 http://dx.doi.org/10.1164/rccm.202108-1896LE |
Ejemplares similares
-
Reply to Jain: High Circulating Plasma Soluble Receptor for Advanced Glycation End-Products in Early COVID-19–associated Acute Respiratory Distress Syndrome: Pathophysiological Significance?
por: Dumas, Guillaume, et al.
Publicado: (2021) -
Importance of Lung Epithelial Injury in COVID-19–associated Acute Respiratory Distress Syndrome: Value of Plasma Soluble Receptor for Advanced Glycation End-Products
por: Kapandji, Natacha, et al.
Publicado: (2021) -
Changes in Plasma Soluble Receptor for Advanced Glycation End-Products Are Associated with Survival in Patients with Acute Respiratory Distress Syndrome
por: Jabaudon, Matthieu, et al.
Publicado: (2021) -
Pathophysiology of COVID-19-associated acute respiratory distress syndrome
por: Narayan, Ananthu, et al.
Publicado: (2021) -
Pathophysiology of COVID-19-associated acute respiratory distress syndrome
por: Camporota, Luigi, et al.
Publicado: (2021)